Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

OncoSec Medical Inc. Reports ImmunoPulse May Prolong Survival Based On Analysis Of Long-Term Survival Data From Phase I Study In Melanoma

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based cancer immunotherapies, released long-term survival results from its Phase I study in patients with metastatic melanoma, evaluating a single treatment cycle of intratumoral plasmid IL-12 (pIL-12) injection with electroporation (EP). Dr. Robert Pierce, Chief Scientific Officer at OncoSec, a co-author of the…

Zogenix, Inc. To Participate In Oppenheimer 25th Annual Healthcare Conference

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 3, 2014 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Stephen Farr, President, and Ann Rhoads, Chief Financial…

Arcturus Therapeutics To Present At The

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 3, 2014 /PRNewswire/ –Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced its participation on two panel discussions at the Genetic Rx Conference taking place at Harvard Medical School on December…

Neurocrine Biosciences, Inc. To Present At The 25th Annual Oppenheimer Healthcare Conference

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 4, 2014 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 25th Annual Oppenheimer Healthcare Conference in New York City…

Neurocrine Biosciences, Inc. To Present At The 25th Annual Oppenheimer Healthcare Conference

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 4, 2014 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 25th Annual Oppenheimer Healthcare Conference in New York City…

Arcturus Therapeutics To Present At The

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 3, 2014 /PRNewswire/ –Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced its participation on two panel discussions at the Genetic Rx Conference taking place at Harvard Medical School on December…

Evofem, Inc. Appoints <b>Chad Putnam</b> As Chief Financial Officer

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 2, 2014 (GLOBE NEWSWIRE) — Evofem, Inc. announced that it appointed Chad Putnam as Chief Financial Officer effective immediately. Mr. Putnam will report to Saundra Pelletier, Chief Executive Officer of Evofem, Inc.

Cytori Therapeutics, Inc.’ Investor Presentation Now Available For On-Demand Viewing

December 4, 2014 – 5:00 pm | Edit Post

NEW YORK and SAN DIEGO, Dec. 5, 2014 /CNW/ — Cytori Therapeutics (NASDAQ: CYTX), today announced that the presentation and corporate update given on December 4 by President and CEO Marc Hedrick, M.D. is now available for on-demand viewing at VirtualInvestorConferences.com.LINK: http://virtualinvestorconferences.com > red “watch company presentations now” buttonCytori’s presentation…

NEMUS To Move Forward With Cannabinoid-Based Therapy For Open-Angle Glaucoma

December 4, 2014 – 5:00 pm | Edit Post

COSTA MESA, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) — NEMUS Bioscience, Inc. (OTC:NMUS) reports that data recently presented at the American Association of Pharmaceutical Scientists (AAPS) meeting in San Diego by Dr. Soumyajit Majumdar, Associate Professor of Pharmaceutics, University of Mississippi…

Organovo To Present At The 25th Annual Oppenheimer Healthcare Conference

December 4, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 4, 2014 /PRNewswire/ –Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the 25th Annual Oppenheimer Healthcare Conference, which will be held in